Publication | Open Access
Phase I clinical trial of fixed–dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation
21
Citations
30
References
2004
Year
The combination of gemcitabine and DTIC possesses an acceptable toxicity profile and may warrant further investigation in patients with ASTS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1